Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Emberton

Showing results (121-130 of 474) with videos related to

Pageof 48
Sort By:
Nature Reviews. Urology|December 16, 2015
The challenging landscape of medical device approval in localized prostate cancerMassimo Valerio, Mark Emberton, Scott E Eggener, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 5, 2013
Role of magnetic resonance imaging in defining a biopsy strategy for detection of prostate cancerAshley J Ridout, Veeru Kasivisvanathan, Mark Emberton, et al.
IEEE Access : Practical Innovations, Open Solutions|October 9, 2023
Deep Learning-Based Long Term Mortality Prediction in the National Lung Screening TrialYaozhi Lu, Shahab Aslani, Mark Emberton, et al.
Urologic Oncology|December 17, 2013
Defining the level of evidence for technology adoption in the localized prostate cancer pathwayMassimo Valerio, Ahmed El-Shater Bosaily, Mark Emberton, et al.
The Journal of Urology|May 29, 2003
Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptomsGuy Vallancien, Mark Emberton, Niels Harving, et al.
BMJ (Clinical Research Ed.)|June 24, 2010
Volume-mortality for cystectomy. Centralisation of cancer services vindicatedPaul J Cathcart, Jan van der Meulen, Mark Emberton, et al.
BJU International|September 13, 2005
Does photodynamic therapy have the necessary attributes to become a future treatment for organ-confined prostate cancer?Caroline M Moore, Ivan M Hoh, Stephen G Bown, et al.
Prostate Cancer and Prostatic Diseases|January 22, 2019
Exploring the risk-reward balance in focal therapy for prostate cancer-a contribution to the debateAnouck Kluytmans, Jurgen J Fütterer, Mark Emberton, et al.
BJU International|August 2, 2006
Information booklets for men with localized prostate cancer need to be improvedTet L Yap, James Armitage, Mark Emberton, et al.
European Urology Oncology|July 11, 2020
Prostate Imaging Quality (PI-QUAL): A New Quality Control Scoring System for Multiparametric Magnetic Resonance Imaging of the Prostate from the PRECISION trialFrancesco Giganti, Clare Allen, Mark Emberton, et al.
Pageof 48

Showing results (121-130 of 474) with videos related to

Sort By:
Pageof 48
Nature Reviews. Urology|December 16, 2015
The challenging landscape of medical device approval in localized prostate cancerMassimo Valerio, Mark Emberton, Scott E Eggener, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 5, 2013
Role of magnetic resonance imaging in defining a biopsy strategy for detection of prostate cancerAshley J Ridout, Veeru Kasivisvanathan, Mark Emberton, et al.
IEEE Access : Practical Innovations, Open Solutions|October 9, 2023
Deep Learning-Based Long Term Mortality Prediction in the National Lung Screening TrialYaozhi Lu, Shahab Aslani, Mark Emberton, et al.
Urologic Oncology|December 17, 2013
Defining the level of evidence for technology adoption in the localized prostate cancer pathwayMassimo Valerio, Ahmed El-Shater Bosaily, Mark Emberton, et al.
The Journal of Urology|May 29, 2003
Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptomsGuy Vallancien, Mark Emberton, Niels Harving, et al.
BMJ (Clinical Research Ed.)|June 24, 2010
Volume-mortality for cystectomy. Centralisation of cancer services vindicatedPaul J Cathcart, Jan van der Meulen, Mark Emberton, et al.
BJU International|September 13, 2005
Does photodynamic therapy have the necessary attributes to become a future treatment for organ-confined prostate cancer?Caroline M Moore, Ivan M Hoh, Stephen G Bown, et al.
Prostate Cancer and Prostatic Diseases|January 22, 2019
Exploring the risk-reward balance in focal therapy for prostate cancer-a contribution to the debateAnouck Kluytmans, Jurgen J Fütterer, Mark Emberton, et al.
BJU International|August 2, 2006
Information booklets for men with localized prostate cancer need to be improvedTet L Yap, James Armitage, Mark Emberton, et al.
European Urology Oncology|July 11, 2020
Prostate Imaging Quality (PI-QUAL): A New Quality Control Scoring System for Multiparametric Magnetic Resonance Imaging of the Prostate from the PRECISION trialFrancesco Giganti, Clare Allen, Mark Emberton, et al.
Pageof 48